The Goodman Faculty of Life Sciences, Bar Ilan University, Ramat Gan, Israel.
Department of Mathematics, Bar Ilan University, Ramat Gan, Israel.
Immunogenetics. 2021 Apr;73(2):163-173. doi: 10.1007/s00251-020-01200-7. Epub 2021 Jan 21.
Restoration of T cell repertoire diversity after allogeneic bone marrow transplantation (allo-BMT) is crucial for immune recovery. T cell diversity is produced by rearrangements of germline gene segments (V (D) and J) of the T cell receptor (TCR) α and β chains, and selection induced by binding of TCRs to MHC-peptide complexes. Multiple measures were proposed for this diversity. We here focus on the V-gene usage and the CDR3 sequences of the beta chain. We compared multiple T cell repertoires to follow T cell repertoire changes post-allo-BMT in HLA-matched related donor and recipient pairs. Our analyses of the differences between donor and recipient complementarity determining region 3 (CDR3) beta composition and V-gene profile show that the CDR3 sequence composition does not change during restoration, implying its dependence on the HLA typing. In contrast, V-gene usage followed a time-dependent pattern, initially following the donor profile and then shifting back to the recipients' profile. The final long-term repertoire was more similar to that of the recipient's original one than the donor's; some recipients converged within months, while others took multiple years. Based on the results of our analyses, we propose that donor-recipient V-gene distribution differences may serve as clinical biomarkers for monitoring immune recovery.
异基因骨髓移植(allo-BMT)后 T 细胞 repertoire 多样性的恢复对于免疫重建至关重要。T 细胞多样性是通过 T 细胞受体(TCR)α和β链的胚系基因片段(V(D)和 J)的重排以及 TCR 与 MHC-肽复合物结合所诱导的选择产生的。已经提出了多种措施来实现这种多样性。我们在这里重点关注β链的 V 基因使用和 CDR3 序列。我们比较了多个 T 细胞 repertoire,以跟踪 HLA 匹配的相关供体和受体对 allo-BMT 后 T 细胞 repertoire 的变化。我们对供体和受体互补决定区 3(CDR3)β组成和 V 基因谱之间差异的分析表明,CDR3 序列组成在恢复过程中不会发生变化,这意味着它依赖于 HLA 分型。相比之下,V 基因的使用遵循时间依赖性模式,最初遵循供体的模式,然后回落到受体的模式。最终的长期 repertoire 与受体的原始 repertoire 更相似,而不是供体的;一些受体在数月内收敛,而另一些则需要多年时间。基于我们分析的结果,我们提出供体-受体 V 基因分布差异可作为监测免疫重建的临床生物标志物。